Company: REVB
Filing Date: 2025-05-29
Form Type: PRE 14A
Source: 0000950170-25-078948
Chunk: 73

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-29
Form: PRE 14A
Chunk 73
---
 of common stock held directly by Mr. Roper (ii) 181 shares of common stock from the February 11, 2025 RSA grant to Mr. Roper, and (iii) 13 shares of common stock underlying Stock Options exercisable within 60 days by Mr. Roper                                                                                                        |
| (5) | Consists of 181 shares of common stock from the February 11, 2025 RSA grant to Dr. Chawla                                                                                                                                                                                                                                                                          |
| (6) | Consists of (i) 28 shares of common stock held by The Zygmont Family Trust Dated October 25, 2016, (ii) 13 shares of common stock held by Czeslaw Capital Fund, LLC, (iii) 15,048 shares of common stock from the February 11, 2025 RSA grant to Mr. Zygmont, and (iv) 1 shares of common stock underlying Stock Options exercisable within 60 days by Mr. Zygmont |

Securities Authorized for Issuance Under Equity Incentive Plans The following table contains information about our equity compensation plans as of December 31, 2024. As of such date, we had outstanding awards under one equity compensation plan: our 2021 Equity Incentive Plan.

<div align='center'>54</div>

| Plan Category                                              |     | Number of Securities to 
 be Issued Upon Exercise 
 of Outstanding Options, 
 Warrants and Rights(1)  
 (a)                     |    |     | Weighted-Average       
 Exercise Price of      
 Outstanding Options,   
 Warrants and Rights(2) 
 (b)                    |          |     | Number of Securities    
 Remaining Available for 
 Future Issuance Under   
 Equity Compensation     
 Plans (Excluding        
 Securities Reflected    
 in Column (a))          
 (c)                     |        |
|:-----------------------------------------------------------|:----|:------------------------|---:|:----|:-----------------------|---------:|:----|:------------------------|-------:|
| Equity compensation plans approved by security holders     |     |                         | 67 |     | $                      | 3,555.83 |     |                         | 10,142 |
| Equity compensation plans not approved by security holders |     | —                       |    |     | —                      |          |     | —                       |        |
| Total                                                      |     |                         | 67 |     | $                      | 3,555.83 |     |